PGJ2 antagonizes NF-κB-induced HIV-1 LTR activation in colonic epithelial cells

被引:10
作者
Boisvert, Melissa [1 ]
Cote, Sandra [1 ]
Vargas, Amandine [3 ,4 ]
Pasvanis, Stamatoula [1 ]
Bounou, Salim [2 ]
Barbeau, Benoit [3 ,4 ]
Dumais, Nancy [1 ]
机构
[1] Univ Sherbrooke, Fac Sci, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada
[2] Univ Sherbrooke, Fac Med, Dept Pediat, Div Immunol, Sherbrooke, PQ J1H 5N4, Canada
[3] Univ Quebec, Dept Sci Biol, Montreal, PQ H2X 3X8, Canada
[4] Univ Quebec, BioMed Res Ctr, Montreal, PQ H2X 3X8, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
PGJ(2); HIV; transcription; mucosal transmission; NF-kappa B;
D O I
10.1016/j.virol.2008.07.023
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Intestinal epithelial cells play an important role in early stages of HIV-1 infection and long-term persistence of the virus. Here we determined the mechanism that regulates HIV-1 activation via prostaglandin J(2) (PGJ(2)) in Caco-2 cells. We showed that treatment of Caco-2 cells with PGJ2 decreased the infectivity of a luciferase reporter virus, pHXB-luc, as well as HIV production following infection of cells with a X4-tropic virus by antagonizing sodium butyrate, a cellular activator known to induce HIV-1 transcription. Transfection of intestinal epithelial cells such as Caco-2, HT-29 and SW620 cells with full-length HIV-1 LTR (pLTR-luc) revealed that PGJ2 reduced HIV-1 LTR-mediated reporter gene activity. The involvement of NF-kappa B in the PGJ(2)-dependent down-regulation of HIV-1 transcription was further assessed using the kappa B-regulated luciferase-encoding vectors. In Caco-2 cells, PGJ2 decreased IKK activity, resulting in reduced NF-kappa B translocation to the nucleus. Since sodium butyrate has been associated with a chronic stress response in AIDS patients, Our results suggest that addition of PGJ2 in the environment of infected intestinal epithelial cells could reduce HIV-1 transcription. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 96 条
[71]   ANTIVIRAL EFFECT OF PROSTAGLANDINS OF THE A-SERIES - INHIBITION OF VACCINIA VIRUS-REPLICATION IN CULTURED-CELLS [J].
SANTORO, MG ;
JAFFE, BM ;
GARACI, E ;
ESTEBAN, M .
JOURNAL OF GENERAL VIROLOGY, 1982, 63 (DEC) :435-440
[72]   THE RELATIONSHIP BETWEEN PROSTAGLANDINS AND VIRUS-REPLICATION - ENDOGENOUS PROSTAGLANDIN SYNTHESIS DURING INFECTION AND THE EFFECT OF EXOGENOUS PGA ON VIRUS PRODUCTION IN DIFFERENT CELL-LINES AND IN PERSISTENTLY INFECTED-CELLS [J].
SANTORO, MG ;
BENEDETTO, A ;
ZANIRATTI, S ;
GARACI, E ;
JAFFE, BM .
PROSTAGLANDINS, 1983, 25 (03) :353-364
[73]   ANTIVIRAL ACTIVITY OF A SYNTHETIC ANALOG OF PROSTAGLANDIN-A IN MICE INFECTED WITH INFLUENZA-A VIRUS [J].
SANTORO, MG ;
FAVALLI, C ;
MASTINO, A ;
JAFFE, BM ;
ESTEBAN, M ;
GARACI, E .
ARCHIVES OF VIROLOGY, 1988, 99 (1-2) :89-100
[74]   PROSTAGLANDIN-A COMPOUNDS AS ANTI-VIRAL AGENTS [J].
SANTORO, MG ;
BENEDETTO, A ;
CARRUBA, G ;
GARACI, E ;
JAFFE, BM .
SCIENCE, 1980, 209 (4460) :1032-1034
[75]   New embo member's review -: NF-κB and virus infection:: who controls whom [J].
Santoro, MG ;
Rossi, A ;
Amici, C .
EMBO JOURNAL, 2003, 22 (11) :2552-2560
[76]   Differentiation and reversal of malignant changes in colon cancer through PPARγ [J].
Sarraf, P ;
Mueller, E ;
Jones, D ;
King, FJ ;
DeAngelo, DJ ;
Partridge, JB ;
Holden, SA ;
Chen, LB ;
Singer, S ;
Fletcher, C ;
Spiegelman, BM .
NATURE MEDICINE, 1998, 4 (09) :1046-1052
[77]   15d-PGJ2:: The anti-inflammatory prostaglandin? [J].
Scher, JU ;
Pillinger, MH .
CLINICAL IMMUNOLOGY, 2005, 114 (02) :100-109
[78]  
Schoonjans K, 1996, J LIPID RES, V37, P907
[79]   RAPID DETECTION OF OCTAMER BINDING-PROTEINS WITH MINI-EXTRACTS, PREPARED FROM A SMALL NUMBER OF CELLS [J].
SCHREIBER, E ;
MATTHIAS, P ;
MULLER, MM ;
SCHAFFNER, W .
NUCLEIC ACIDS RESEARCH, 1989, 17 (15) :6419-6419
[80]   Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments [J].
Shepard, RN ;
Schock, J ;
Robertson, K ;
Shugars, DC ;
Dyer, J ;
Vernazza, P ;
Hall, C ;
Cohen, MS ;
Fiscus, SA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (04) :1414-1418